Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
Update on acquired tetracycline resistance genes
Roberts, M. C. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.02.034 · Cited by 1,010
Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry
Beale, J. M., & Block, J. H. (2011) · Andalas University Repository (Andalas University) · Cited by 914
Tetracycline antibiotics and resistance mechanisms
Nguyen, F., Starosta, A. L., Arenz, S., Sohmen, D., Dönhöfer, A., & Wilson, D. N. (2014) · Biological Chemistry · doi:10.1515/hsz-2013-0292 · Cited by 528
The history of the tetracyclines
Nelson, M. L., & Levy, S. B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06354.x · Cited by 468
"Compendium of pharmaceuticals and specialties".
Krogh, C. (1983) · PubMed · Cited by 411
New antibiotics for bad bugs: where are we?
Bassetti, M., Merelli, M., Temperoni, C., & Astilean, A. (2013) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-12-22 · Cited by 403
Thaker, M., Spanogiannopoulos, P., & Wright, G. D. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0172-6 · Cited by 378
The Glycylcyclines: A Comparative Review with the Tetracyclines
Zhanel, G. G., Homenuik, K., Nichol, K., Noreddin, A., Vercaigne, L., Embil, J., Gin, A., Karlowsky, J. A., & Hoban, D. J. (2004) · Drugs · doi:10.2165/00003495-200464010-00005 · Cited by 306
Self-citationSutcliffe, J. A., O'Brien, W., Fyfe, C., & Grossman, T. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-13 · Cited by 235
Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination
Gin, A. S., Dilay, L., Karlowsky, J. A., Walkty, A. J., Rubinstein, E., & Zhanel, G. G. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.3.365 · Cited by 194
Self-citationCompendium of Pharmaceuticals and Specialties
Hartleib, C. J. (1974) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/31.11.1085a · Cited by 169
Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic
Grossman, T. H., Starosta, A. L., Fyfe, C., O'Brien, W., Rothstein, D. M., Mikolajka, A., Wilson, D. N., & Sutcliffe, J. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06187-11 · Cited by 162
Zhanel, G. G., Adam, H. J., Baxter, M. R., Fuller, J., Nichol, K. A., Denisuik, A. J., Lagacé-Wiens, P. R. S., Walkty, A. J., Karlowsky, J. A., Schweizer, F., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt022 · Cited by 151
Self-citationAbdallah, M., Olafisoye, O., Cortes, C. D., Urban, C. M., Landman, D., & Quale, J. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04809-14 · Cited by 144
Solomkin, J. S., Ramesh, M. K., Česnauskas, G., Novikovs, N., Stefanova, P. P., Sutcliffe, J. A., Walpole, S. M., & Horn, P. T. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01614-13 · Cited by 129
Xiao, X.-Y., Hunt, D. K., Zhou, J., Clark, R. B., Dunwoody, N., Fyfe, C., Grossman, T. H., O’Brien, W. J., Plamondon, L., Rönn, M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201465w · Cited by 126
Meagher, A. K., Passarell, J. A., Cirincione, B. B., Wart, S. A. V., Liolios, K., Babinchak, T., Ellis‐Grosse, E. J., & Ambrose, P. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01084-06 · Cited by 123
Ertapenem: review of a new carbapenem
Zhanel, G. G., Johanson, C., Embil, J. M., Noreddin, A. M., Gin, A. S., Vercaigne, L. M., & Hoban, D. J. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.1.23 · Cited by 119
Self-citationConnors, K. P., Housman, S. T., Pope, J. S., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02036-13 · Cited by 117
Passarell, J. A., Meagher, A. K., Liolios, K., Cirincione, B. B., Wart, S. A. V., Babinchak, T., Ellis‐Grosse, E. J., & Ambrose, P. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00813-07 · Cited by 107
Tigecycline: a novel glycylcycline antibiotic
Zhanel, G. G., Karlowsky, J. A., Rubinstein, E., & Hoban, D. J. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.1.9 · Cited by 102
Self-citationDrug Interaction Facts 2012: The Authority on Drug Interactions
(2012) · Journal of Pharmacy Technology · doi:10.1177/875512251202800209 · Cited by 85
Drug Interactions Analysis and Management 2009
Ranieri, M. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181c0d593 · Cited by 78
Thompson, S. A., Maani, E. V., Lindell, A. H., King, C. J., & McArthur, J. V. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.02511-06 · Cited by 77
Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy
Clark, R. B., Hunt, D. K., He, M., Achorn, C., Chen, C.-L., Deng, Y., Fyfe, C., Grossman, T. H., Hogan, P. C., O’Brien, W. J., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201467r · Cited by 74
Process R&D of Eravacycline: The First Fully Synthetic Fluorocycline in Clinical Development
Ronn, M., Zhu, Z., Hogan, P. C., Zhang, W., Niu, J., Katz, C. E., Dunwoody, N., Gilicky, O., Deng, Y., Hunt, D. K., et al. (2013) · Organic Process Research & Development · doi:10.1021/op4000219 · Cited by 62
Eravacycline for the treatment of intra-abdominal infections
Bassetti, M., & Righi, E. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.965253 · Cited by 54
Kazimierczak, K. A., Rincón, M. T., Patterson, A. J., Martin, J. C., Young, P., Flint, H. J., & Scott, K. P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00308-08 · Cited by 52
Eravacycline (TP-434) Is Efficacious in Animal Models of Infection
Grossman, T. H., Murphy, T. M., Slee, A., Lofland, D., & Sutcliffe, J. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04354-14 · Cited by 45
Warburton, P., Ciric, L., Lerner, A., Seville, L., Roberts, A. P., Mullany, P. P., & Allan, E. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks351 · Cited by 41
Brown, M. G., Mitchell, E., & Balkwill, D. L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00640-08 · Cited by 31
Eravacycline (TP-434) Is Active In Vitro against Biofilms Formed by Uropathogenic Escherichia coli
Grossman, T. H., O'Brien, W., Kerstein, K. O., & Sutcliffe, J. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04967-14 · Cited by 29
You, Y., Hilpert, M., & Ward, M. J. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt127 · Cited by 21
Cited by
Terreni, M., Taccani, M., & Pregnolato, M. (2021) · Molecules · doi:10.3390/molecules26092671 · Cited by 596
Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options
Sheu, C.-C., Chang, Y.-T., Lin, S.-Y., Chen, Y.-H., & Hsueh, P.-R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00080 · Cited by 520
Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
Suay-García, B., & Pérez-Gracia, M. T. (2019) · Antibiotics · doi:10.3390/antibiotics8030122 · Cited by 344
Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections
Ma, Y., Wang, C., Li, Y., Li, J., Wan, Q., Chen, J., Tay, F. R., & Niu, L. (2020) · Advanced Science · doi:10.1002/advs.201901872 · Cited by 314
New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
Isler, B., Doi, Y., Bonomo, R. A., & Paterson, D. L. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01110-18 · Cited by 293
Metadata
- Authors
- Zhanel, G. G., Cheung, D., Adam, H., Zelenitsky, S., Golden, A., Schweizer, F., Gorityala, B., Lagacé-Wiens, P. R. S., Walkty, A., Gin, A. S., Hoban, D. J., & Karlowsky, J. A.
- Venue
- Drugs
- Published
- 2016-02-10
- Volume
- 76
- Issue
- 5
- Pages
- 567-588
- ISSN
- 0012-6667 (ISSN-L)
- 1179-1950
- OpenAlex
- W2266943560
- Cited by
- 317
- References
- 35
- FWCI
- 18.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.